Home » Newsletters » BioWorld

BioWorld

April 10, 1991

View Archived Issues

JOURNAL SCAN STUDIES OF IL-1ra AND bFGF ANALOGS

OCLASSEN SIGNS CO-MARKETING DEAL FOR ANTIBIOTIC

CAMBRIDGE BIO ACQUIRES IRISH COMPANY

IMMUNE RESPONSE FILES FOR OFFERING

BIOTECH STOCKS FOLLOW WEAK MARKET

VENTREX TO CUT PRODUCTS, WORK FORCE

PATENT SWEETENS BIOSPHERICS' STOCK

NEGATIVE REPORT HURTS IMMUNEX'S STOCK

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...